143 related articles for article (PubMed ID: 15585389)
1. Proteomic analysis of SEG-1 human Barrett's-associated esophageal adenocarcinoma cells treated with keyhole limpet hemocyanin.
Vona-Davis L; Vincent T; Zulfiqar S; Jackson B; Riggs D; McFadden DW
J Gastrointest Surg; 2004 Dec; 8(8):1018-23. PubMed ID: 15585389
[TBL] [Abstract][Full Text] [Related]
2. Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's esophageal adenocarcinoma.
McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
Am J Surg; 2003 Nov; 186(5):552-5. PubMed ID: 14599624
[TBL] [Abstract][Full Text] [Related]
3. Peptide YY inhibits the growth of Barrett's esophageal adenocarcinoma in vitro.
McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
Am J Surg; 2004 Nov; 188(5):516-9. PubMed ID: 15546561
[TBL] [Abstract][Full Text] [Related]
4. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L in Barrett's esophagus with dysplasia and adenocarcinoma.
Popnikolov NK; Gatalica Z; Adegboyega PA; Norris BA; Pasricha PJ
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):161-5. PubMed ID: 16785783
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
8. Hemocyanin from the keyhole limpet Megathura crenulata (KLH) carries a novel type of N-glycans with Gal(beta1-6)Man-motifs.
Kurokawa T; Wuhrer M; Lochnit G; Geyer H; Markl J; Geyer R
Eur J Biochem; 2002 Nov; 269(22):5459-73. PubMed ID: 12423344
[TBL] [Abstract][Full Text] [Related]
9. Corn-derived carbohydrate inositol hexaphosphate inhibits Barrett's adenocarcinoma growth by pro-apoptotic mechanisms.
McFadden DW; Riggs DR; Jackson BJ; Cunningham C
Oncol Rep; 2008 Feb; 19(2):563-6. PubMed ID: 18202808
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
11. Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.
Derks S; Nason KS; Liao X; Stachler MD; Liu KX; Liu JB; Sicinska E; Goldberg MS; Freeman GJ; Rodig SJ; Davison JM; Bass AJ
Cancer Immunol Res; 2015 Oct; 3(10):1123-1129. PubMed ID: 26081225
[TBL] [Abstract][Full Text] [Related]
12. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
13. Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence.
Davelaar AL; Straub D; Buttar NS; Fockens P; Krishnadath KK
Scand J Gastroenterol; 2015 Mar; 50(3):321-32. PubMed ID: 25562781
[TBL] [Abstract][Full Text] [Related]
14. Secretory Phospholipase A
Gergen AK; Jarrett MJ; Li A; White AM; Meng X; Fullerton DA; Weyant MJ
J Surg Res; 2021 Mar; 259():562-568. PubMed ID: 33261858
[TBL] [Abstract][Full Text] [Related]
15. [Endoscopic diagnosis of Barrett's adenocarcinoma].
Yoshio H; Takashi Y; Mitsuyo H; Nobuhiko Y; Tatsurou T; Kazuhiko S; Yoko H; Shigemasa I; Hisanaga M; Osamu H; Katsuyoshi S; Seishi U; Matsushita H; Masahiko T
Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):244-8. PubMed ID: 10379534
[TBL] [Abstract][Full Text] [Related]
16. In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line.
Morgan C; Alazawi W; Sirieix P; Freeman T; Coleman N; Fitzgerald R
Am J Gastroenterol; 2004 Feb; 99(2):218-24. PubMed ID: 15046208
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line.
Keswani RN; Chumsangsri A; Mustafi R; Delgado J; Cohen EE; Bissonnette M
Dis Esophagus; 2008; 21(6):514-21. PubMed ID: 18840136
[TBL] [Abstract][Full Text] [Related]
19. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
[TBL] [Abstract][Full Text] [Related]
20. Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy.
Doran ST; Falk GL; Somorjai RL; Lean CL; Himmelreich U; Philips J; Russell P; Dolenko B; Nikulin AE; Mountford CE
Am J Surg; 2003 Mar; 185(3):232-8. PubMed ID: 12620562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
